Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Qingcai Meng

Showing results (51-60 of 90) with videos related to

Pageof 9
Sort By:
Frontiers in Oncology|April 29, 2021
Identification of the Roles of a Stemness Index Based on mRNA Expression in the Prognosis and Metabolic Reprograming of Pancreatic Ductal AdenocarcinomaRong Tang, Xiaomeng Liu, Wei Wang, et al.
Frontiers in Oncology|March 15, 2021
Hyperdense Pancreatic Ductal Adenocarcinoma: Clinical Characteristics and Proteomic LandscapeHe Xu, Jie Hua, Qingcai Meng, et al.
Translational Oncology|May 14, 2023
Integrated analysis revealed hypoxia signatures and LDHA related to tumor cell dedifferentiation and unfavorable prognosis in pancreatic adenocarcinoma: Hypoxia in PDACMingwei Dong, Rong Tang, Wei Wang, et al.
Cellular and Molecular Life Sciences : CMLS|June 16, 2021
Overcoming chemoresistance by targeting reprogrammed metabolism: the Achilles' heel of pancreatic ductal adenocarcinomaAbudureyimu Tuerhong, Jin Xu, Si Shi, et al.
Oncogene|April 15, 2022
RNA N6-methyladenosine demethylase FTO promotes pancreatic cancer progression by inducing the autocrine activity of PDGFC in an m<sup>6</sup>A-YTHDF2-dependent mannerZhen Tan, Si Shi, Jin Xu, et al.
International Journal of Molecular Sciences|October 23, 2021
Ferroptosis: At the Crossroad of Gemcitabine Resistance and Tumorigenesis in Pancreatic CancerJianhui Yang, Jin Xu, Bo Zhang, et al.
Computational and Structural Biotechnology Journal|August 11, 2022
Turning towards nonimmunoreactive tumors: Evaluation of cancer-associated fibroblasts enables prediction of the immune microenvironment and treatment sensitivity in pancreatic cancerSiyuan Lu, Jie Hua, Jin Xu, et al.
Current Oncology (Toronto, Ont.)|March 28, 2023
Cuproptosis-Related Gene <i>DLAT</i> as a Novel Biomarker Correlated with Prognosis, Chemoresistance, and Immune Infiltration in Pancreatic Adenocarcinoma: A Preliminary Study Based on Bioinformatics AnalysisZengli Fang, Wei Wang, Yuan Liu, et al.
Molecular Cancer|August 22, 2021
Circular RNA CircEYA3 induces energy production to promote pancreatic ductal adenocarcinoma progression through the miR-1294/c-Myc axisZeyin Rong, Si Shi, Zhen Tan, et al.
International Journal of Molecular Sciences|February 25, 2023
Mechanical Regulation of Redox Balance via the Induction of the PIN1/NRF2/ARE Axis in Pancreatic CancerChen Liang, Zeyin Rong, Abudureyimu Tuerhong, et al.
Pageof 9

Showing results (51-60 of 90) with videos related to

Sort By:
Pageof 9
Frontiers in Oncology|April 29, 2021
Identification of the Roles of a Stemness Index Based on mRNA Expression in the Prognosis and Metabolic Reprograming of Pancreatic Ductal AdenocarcinomaRong Tang, Xiaomeng Liu, Wei Wang, et al.
Frontiers in Oncology|March 15, 2021
Hyperdense Pancreatic Ductal Adenocarcinoma: Clinical Characteristics and Proteomic LandscapeHe Xu, Jie Hua, Qingcai Meng, et al.
Translational Oncology|May 14, 2023
Integrated analysis revealed hypoxia signatures and LDHA related to tumor cell dedifferentiation and unfavorable prognosis in pancreatic adenocarcinoma: Hypoxia in PDACMingwei Dong, Rong Tang, Wei Wang, et al.
Cellular and Molecular Life Sciences : CMLS|June 16, 2021
Overcoming chemoresistance by targeting reprogrammed metabolism: the Achilles' heel of pancreatic ductal adenocarcinomaAbudureyimu Tuerhong, Jin Xu, Si Shi, et al.
Oncogene|April 15, 2022
RNA N6-methyladenosine demethylase FTO promotes pancreatic cancer progression by inducing the autocrine activity of PDGFC in an m<sup>6</sup>A-YTHDF2-dependent mannerZhen Tan, Si Shi, Jin Xu, et al.
International Journal of Molecular Sciences|October 23, 2021
Ferroptosis: At the Crossroad of Gemcitabine Resistance and Tumorigenesis in Pancreatic CancerJianhui Yang, Jin Xu, Bo Zhang, et al.
Computational and Structural Biotechnology Journal|August 11, 2022
Turning towards nonimmunoreactive tumors: Evaluation of cancer-associated fibroblasts enables prediction of the immune microenvironment and treatment sensitivity in pancreatic cancerSiyuan Lu, Jie Hua, Jin Xu, et al.
Current Oncology (Toronto, Ont.)|March 28, 2023
Cuproptosis-Related Gene <i>DLAT</i> as a Novel Biomarker Correlated with Prognosis, Chemoresistance, and Immune Infiltration in Pancreatic Adenocarcinoma: A Preliminary Study Based on Bioinformatics AnalysisZengli Fang, Wei Wang, Yuan Liu, et al.
Molecular Cancer|August 22, 2021
Circular RNA CircEYA3 induces energy production to promote pancreatic ductal adenocarcinoma progression through the miR-1294/c-Myc axisZeyin Rong, Si Shi, Zhen Tan, et al.
International Journal of Molecular Sciences|February 25, 2023
Mechanical Regulation of Redox Balance via the Induction of the PIN1/NRF2/ARE Axis in Pancreatic CancerChen Liang, Zeyin Rong, Abudureyimu Tuerhong, et al.
Pageof 9